Coherus Oncology (8C5.F) Q2 2024 Earnings

9MayConfirmed
Q2 2023
Q3 2023
Q4 2023
Q2 2024
-0.65
-0.18
0.3
0.77

Details

Expected EPS
-0.23509434159999998
Actual EPS
0.769576
Surprise EPS
1
Surprise Percent
+427.35%

Description

Coherus Oncology (8C5.F) has reported earnings of 0.769576 per share for Q2 2024.

0 Comments

Share your thoughts